한글목차

세계 온열 암 치료 시장의 미래는 유방암, 간암, 연부육종, 두경부 종양, 전립선암 시장에 기회가 있어 유망한 것으로 평가되고 있습니다. 세계 온열 암 치료 시장은 2025년부터 2031년까지 5.8%의 CAGR로 2031년까지 약 2억 7,960만 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 전 세계 암 발병률 증가, 비침습적 암 치료에 대한 인식과 수용성 증가, 나노입자를 통한 온열요법의 인기 증가입니다.

• Lucintel의 예측에 따르면, 유형별로는 국소 온열요법 시스템이 예측 기간 동안 높은 성장세를 보일 것으로 예상됩니다.
• 용도별로는 유방암이 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.
• 지역별로는 APAC 지역이 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

온열 암 치료 시장의 전략적 성장 기회

온열 암 치료 시장의 전략적 성장 기회는 진보와 혁신이 시장 확대로 이어질 수 있는 분야를 의미합니다. 이러한 기회는 다양한 용도와 지역에 걸쳐 있으며, 환자의 예후를 개선할 수 있는 잠재적인 수요 증가의 원천으로 간주될 수 있습니다. 따라서 이해관계자들이 이러한 유형의 치료와 관련된 새로운 트렌드와 새로운 접근법을 활용하려면 이러한 기회를 파악하는 것이 필수적입니다.

• 병용요법 : 영향 : 화학요법, 방사선요법, 표적치료와 온열요법의 병용요법은 반응률 향상에 도움이 됩니다. 그 결과, 다제 병용요법을 사용한 난소암 사례에 비해 종양 조절이 향상되고 부작용이 감소한다(Gonzales et al). 예를 들어, 여러 종류의 암 치료에서 병용요법의 최적화를 위한 임상시험이 조사되고 있습니다.
• 신흥 시장 확대 : 아시아태평양 및 라틴아메리카의 신흥 시장으로 온열요법 치료의 확대는 큰 성장 기회가 될 것입니다. 이들 지역에서는 암 환자 증가와 의료 인프라 개선으로 인해 첨단 암 치료에 대한 수요가 증가하고 있습니다. 이들 지역에 특화된 시장 진입 전략은 온열요법 치료의 채택을 촉진하고 접근성을 높여 시장 성장과 세계 입지를 강화할 수 있습니다.
• 개별화된 치료 접근법 : 환자 개개인의 프로파일과 종양 특성에 따라 온열요법 치료를 개별화하면 부작용을 최소화하면서 치료 효과를 높일 수 있습니다. 이는 치료의 더 나은 표적화와 개별화를 가능하게 하는 첨단 유전체 프로파일링 및 진단 기술을 통해 가능해졌습니다. 이는 온열암 치료의 혁신을 촉진하는 동시에 환자별 치료 결과를 향상시키는 것을 목표로 하는 보다 개인화된 의료로의 전반적인 전환과 일치합니다.
• 기술의 발전 : 안전성과 정확성의 지속적인 개선은 온열 치료 기기 분야에서 현재도 계속되고 있는 지속적인 기술 발전을 통해 확인할 수 있습니다. 새로운 기술 개발은 치료 과정의 효과성을 향상시키고, 많은 사람들에게 채택되어 환자의 편안함을 향상시키고 있습니다. 장비의 능력 향상을 위한 연구개발에 대한 투자는 온열 목적의 암 치료법 강화뿐만 아니라 시장 점유율 측면에서도 큰 이익을 가져다 줄 수 있습니다.
• 공동 연구 및 파트너십 : 기술 개발자, 연구 개발 기관 및 의료 서비스 제공자 간의 전략적 파트너십을 통해 온열 요법 치료의 개발 및 보급을 가속화할 수 있습니다. 혁신과 치료 옵션의 개선은 파트너십을 통해 촉진되는 지식 공유, 자원 풀 및 임상 연구를 통해 달성됩니다. 협력적 노력은 전체 암 치료의 영향력을 확대하고 시장 성장의 원동력이 될 수 있습니다.

온열 암 치료의 시장 확대와 기술 혁신은 병용요법, 개별화된 치료 접근법, 기술 발전, 신흥 시장으로의 확장, 전략적 제휴 등 전략적 성장 기회로 인해 발생합니다. 유방암의 기회는 온열요법 치료의 발전에 중요한 역할을 하고 있으며, 사업 개발에 유용합니다.

온열 암 치료 시장의 촉진요인 및 과제

이 조사는 온열 암 치료 시장의 발전을 형성하는 다양한 촉진요인 및 과제에 대한 인사이트를 제공하는 것을 목표로 합니다. 장비 생산과 관련된 높은 비용은 경쟁사의 초기 진입을 제한하고 이러한 장비에서 얻을 수 있는 이익을 제한하기 때문에 높은 이윤을 제한합니다. 이 보고서는 기업의 해외 진출 능력에 영향을 미치는 요인을 분석합니다.

온열 암 치료 시장을 주도하는 요인은 다음과 같습니다.

1. 기술의 발전 : 기술의 발전 : 기술의 발전은 정확도 향상과 새로운 장치 기술별 온열요법 치료의 효율성을 향상시키고 있습니다. 이러한 개선은 종양 조직을 보다 정확하게 파악하여 환자의 예후를 개선하고 치료 옵션을 확대하는 데 도움이 됩니다. 기기 기술에 대한 연구개발 활동은 시장의 성장과 보급을 촉진합니다.

2. 암 발병률 증가 : 전 세계 암 환자의 증가는 온열요법과 같은 효과적인 치료 옵션에 대한 수요에 영향을 미치고 있습니다. 암 발병률이 증가함에 따라 보완적 또는 혁신적 치료법에 대한 수요가 증가하여 이 시장 부문의 확대로 이어질 것입니다. 업계 데이터 예측에 따르면, 이러한 추세는 장기적으로 지속될 것으로 예상됩니다. 요약하면, 온열요법을 이용한 암 치료는 큰 기회가 있다는 것입니다.

3. 연구 자금의 증가 : 온열요법별 암 치료 개선을 위한 연구개발 활동을 촉진하는 데 있어 정부 및 민간 자금 지원은 중요한 역할을 하고 있습니다. 이러한 재정적 지원은 기술 발전, 임상시험 확대, 시장 성장과 새로운 치료법 창출에 기여하는 기술 혁신을 촉진합니다.

4. 인식과 수용성 향상 : 온열요법의 장점에 대한 의료진과 환자의 인식이 높아지면 온열요법의 채택과 활용이 촉진됩니다. 온열요법은 유방암 여성을 대상으로 한 성공적인 임상시험을 통해 많은 국가에서 승인을 받았습니다. 인지도가 높아짐에 따라 전 세계 종양 클리닉에서 온열요법의 도입이 증가할 것으로 예상됩니다.

온열 암 치료 시장의 과제:

1. 높은 초기 비용 : 온열요법 장비와 치료는 고가이기 때문에 특히 나이지리아를 포함한 아프리카처럼 1인당 소득이 낮거나 의료제도가 발달하지 않은 시장에서는 경제적인 문제로 인해 접근이 제한될 수 있습니다. 암 진단 건수의 증가로 온열요법에 대한 수요가 증가하고 있지만, 높은 비용으로 인해 의료 서비스 제공자가 이 기술을 구입하기 어렵고, 특히 빈곤 지역에서는 그 사용이 제한되어 있습니다. 이러한 비용을 절감하는 것은 접근성을 높이고 환자의 치료 결과를 개선하기 위해 필수적입니다.

2. 제한된 임상적 증거 : 온열요법의 시장 성장은 치료의 효과와 안전성에 대한 충분한 임상적 증거의 부족으로 인해 제한되고 있습니다. 결정적인 임상시험이 없다는 것은 이 치료법의 정당성을 훼손하고, 실행 가능한 옵션으로 사용하기에 충분한 데이터가 없다고 생각하는 의료 서비스 제공자의 회의론을 조장하고 있습니다.

3. 복잡한 규제 절차 : 새로운 온열치료기의 규제 요건과 승인 획득은 어려운 과제입니다. 규제 장벽은 시장 진입을 지연시키고, 개발 비용을 증가시키며, 온열 치료의 성장과 채택을 방해할 수 있습니다.

기술 발전, 암 발병률 증가, 연구 자금 증가, 규제 당국의 지원 및 인식 개선은 온열 암 치료 시장을 형성하는 주요 촉진요인입니다. 그러나 시장 역학은 높은 비용, 제한된 임상적 증거, 규제 장벽과 같은 도전 과제에도 영향을 받고 있습니다. 온열암 치료의 발전과 헬스케어 분야에서의 영향력을 높이기 위해서는 촉진요인을 활용하면서 이러한 문제들을 해결하는 것이 매우 중요합니다.

목차

제1장 주요 요약

제2장 세계의 온열 암 치료 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2019년에서 2031년까지 시장 동향과 예측 분석

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 온열 암 치료 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 온열 암 치료 시장, 유형별
  • 국소 온열요법 시스템
  • 전신 온열요법 시스템
• 세계의 온열 암 치료 시장, 용도별
  • 유방암
  • 간암
  • 연부 육종
  • 두경부 종양
  • 전립선암
  • 기타

제4장 2019년에서 2031년까지 시장 동향과 예측 분석, 지역별

• 세계의 온열 암 치료 시장, 지역별
• 북미의 온열 암 치료 시장
• 유럽의 온열 암 치료 시장
• 아시아태평양의 온열 암 치료 시장
• 기타 지역의 온열 암 치료 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 온열 암 치료 시장 성장 기회, 유형별
  • 세계의 온열 암 치료 시장 성장 기회, 용도별
  • 세계의 온열 암 치료 시장 성장 기회, 지역별
• 세계의 온열 암 치료 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 온열 암 치료 시장 능력 확대
  • 세계의 온열 암 치료 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• PYREXAR Medical
• Celsius43
• Hydrosun
• Oncotherm
• Andromedic
• Yamamoto Vinita
• Chongqing Haifu Medical Technology
• innoMedicus
• Gamida-Cell
• RAND

영문목차

The future of the global hyperthermia cancer treatment market looks promising with opportunities in the breast cancer, liver cancer, soft tissue sarcoma, head & neck tumor, and prostate cancer markets. The global hyperthermia cancer treatment market is expected to reach an estimated $279.6 million by 2031 with a CAGR of 5.8% from 2025 to 2031. The major drivers for this market are the increasing incidence of cancer worldwide, growing awareness and acceptance of non-invasive cancer therapies, and the rising popularity of nanoparticle-mediated hyperthermia.

• Lucintel forecasts that, within the type category local hyperthermia system is expected to witness higher growth over the forecast period.
• Within the application category, breast cancer is expected to witness the highest growth over the forecast period.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Hyperthermia Cancer Treatment Market

Emerging trends in the hyperthermia cancer treatment market are driven by advanced technological changes, shifting therapy patterns, and increasing research focus. These trends represent critical developments in the integration of hyperthermia into cancer treatment, offering prospects for innovation and improved patient outcomes. Market stakeholders looking to capitalize on these opportunities must understand these trends to shape the future direction of hyperthermia cancer treatments.

• Integration with Immunotherapy: The combination of hyperthermia and immunotherapy is gaining popularity because it enhances the immune system's response to malignant cells. By inducing heat shock proteins that stimulate immune responses, hyperthermia can increase the effectiveness of immunotherapeutic agents. Clinical trials are showing promising results in terms of improved patient outcomes and reduced tumor sizes. This trend highlights a growing emphasis on combination therapies aimed at improving overall treatment effectiveness and opens new avenues for investigation and clinical implementation.
• Advancements in Hyperthermic Devices: The development of high-precision radiofrequency and microwave systems, among other advanced hyperthermic devices, is revolutionizing cancer treatment. These devices allow for better targeting of tumors by enhancing temperature control, which enables more effective treatments with fewer side effects. As a result, patients experience greater comfort. This trend is driven by ongoing research and technological advancements that expand the capabilities and applications of hyperthermia in cancer therapy.
• Customized Hyperthermic Treatment: Personalized thermal treatment involves considering each patient's unique cancer characteristics and their response to related medications when designing a treatment plan. This approach is supported by advancements in genomics and diagnostic technologies that improve the specificity of hyperthermia therapy. By customizing treatment to suit individual needs, personalized approaches aim to optimize treatment outcomes while minimizing side effects. This reflects the broader trend toward precision medicine and personalized cancer care.
• Combination with Targeted Therapies: Combining hyperthermia with targeted chemotherapy or monoclonal antibodies has shown improved efficacy. By raising the temperature of tumor cells, hyperthermia increases blood flow into these cells and disrupts their repair mechanisms, thereby enhancing the activity of targeted drugs for more effective tumor treatment. Clinical trials are currently investigating this combination approach, which could potentially increase tumor responses while reducing systemic toxicities.
• Growth in Emerging Markets: Hyperthermia treatment is becoming more affordable and accessible, particularly in emerging markets, through efforts to bring advanced treatment options to these regions (Europe PMC). This expansion is driven by the increasing prevalence of cancer and the development of healthcare infrastructure in these markets. Emerging markets provide significant growth opportunities for technology suppliers offering hyperthermia services, signaling a shift toward expanding access to innovative therapies.

The hyperthermia cancer treatment market is evolving, driven by trends such as its integration with immunotherapy, advancements in device technologies, individualized treatment approaches, synergy with targeted therapies, and expansion into new markets. These trends reflect the changes occurring within the hyperthermia landscape, with the potential for improved patient outcomes and expanded market opportunities. As these trends unfold, they will drive innovation and growth in the hyperthermia cancer treatment market.

Recent Developments in the Hyperthermia Cancer Treatment Market

Recent developments in hyperthermia are a reflection of technological advancement, clinical research, and therapeutic integrations. This is affecting the way forward for hyperthermia as an adjunctive therapy for cancer by making it more effective and widening its application scope. Key developments include innovations in hyperthermic devices, integration with other therapies, and increased funding for research purposes. Understanding these developments is vital to comprehend where the market stands now and where it may be heading.

• Technological Innovations: Technological advancements in treating cancer using hyperthermia have seen the introduction of sophisticated equipment such as high-accuracy radiofrequency or microwave systems. Such developments make targeting the heating of tumor tissues much better achievable thus improving treatment outcomes and causing fewer side effects. The recent devices have better control of temperature distribution inside the human body hence ensuring patient safety while undergoing this mode of therapy. Ongoing R&D activities confirm this fact by pushing frontiers farther down thereby expanding possibilities that exist in the application sphere.
• Integration with Immunotherapy: Hyperthermia's combination with immunotherapy represents another major development that improves the efficiency of both therapies. Immune response can be stimulated through heat which then enhances the effectiveness of the immune-modulatory drug leading to tumors being controlled accordingly besides obtaining better results from patients after receiving this therapy. A number of clinical studies show how well these modalities integrate together thus their synergistic action emerges. This is a trend towards combination therapies in oncology and highlights hyperthermia's potential role as a pivotal immunotherapeutic advance.
• Expansion of Clinical Trials: The expansion of clinical trials for hyperthermia cancer treatment is a key development, with new studies investigating various treatment combinations and patient populations. Such trials are necessary to confirm the efficacy of hyperthermia in different types of cancers and treatment environments. More research activities focus on finding optimal procedures for therapy, which would be useful in cases when traditional methods are not efficient enough. The outcomes will then help decision makers realize the importance and boundaries associated with its use thereby accepting it at large scales as a means to treat malignancies better.
• Regulatory Approvals: Recent regulatory approvals for new hyperthermia devices and treatments are driving market growth. Some advanced systems have been approved by regulators such as the FDA and EMA which indicate that they meet safety requirements. Consequently, these endorsements make it possible to commercialize as well as introduce innovations to the wider population thus expanding this sector over time. The regulations play a huge role in ensuring innovative therapies reach patients besides advancing hypothermia therapy as a choice for cancer cure generally.

The hyperthermia cancer treatment market has experienced several recent developments which include; technological innovations, integration with immunotherapy, expansion of clinical trials, regulatory approvals, and increased research funding that have boosted it. The above-mentioned developments indicate a dynamic marketplace that changes over time towards greater efficacy, safety, and accessibility improvements. Such trends will influence the future of hyperthermia as an adjunctive therapy for cancer leading to market expansion.

Strategic Growth Opportunities for Hyperthermia Cancer Treatment Market

It is evidenced by strategic growth opportunities in the hyperthermia cancer treatment market which signify areas where advancements or innovations could lead to market expansion. These opportunities cut across diverse applications and regions hence they can be seen as a potential source of demand increase translating into better patient outcomes. Therefore, identifying these opportunities is vital if stakeholders want to tap into emerging trends as well as novel approaches associated with this kind of therapy in general.

• Combination Therapies: Impact: One way that researchers are approaching this is by combining chemotherapy, radiotherapy, or targeted therapies with hyperthermia which results in improved response rates. Thereby reducing side effects through better tumor control when compared alone to multi-modalities ovarian cases (Gonzales et al). For example, it is being studied in clinical trials that can lead to optimizing the delivery of combination therapies for multi-modal cancer treatments.
• Emerging Markets Expansion: The expansion of Hyperthermia treatment into emerging markets in Asia-Pacific and Latin America provides a significant opportunity for growth. Additionally, there is a growing demand for advanced cancer treatments due to increased cases of cancer and improved healthcare infrastructure in these regions. Market entry strategies specific to these regions could drive adoption and increase access to hyperthermia therapies thereby leading to market growth and global presence.
• Personalized Treatment Approaches: When tailored towards individual patient profiles, as well as tumor characteristics, personalizing hyperthermia treatment improves efficacy while minimizing side effects. As such, this has been made possible through advanced genomic profiling and diagnostic techniques which enable better targeting and tailoring of therapy. This aligns with the overall shift toward more personalized approaches to medicine that aim at enhancing patient-specific treatment outcomes while driving innovation for hyperthermia cancer therapy.
• Technological Advancements: Ongoing improvements in safety features and precision can be seen through continued technological advancements that are still happening within the field of hyperthermia devices. New technological developments have also led to increased effectiveness during treatment processes thus improving patients' comfort levels through adoption by many people. Investing in research and development, aimed at improving device capabilities can result in considerable gains in terms of market share as well as enhanced cancer therapeutics for hyperthermic purposes.
• Collaboration and Partnerships: Hyperthermia treatments' development and adoption can be accelerated through strategic partnerships between technology developers, research institutions, and healthcare providers. Innovations and improved treatment options are achieved through knowledge sharing, resource pooling, and clinical research that is facilitated by partnerships. Collaborative efforts scale up the cancer treatment's overall impact as well as drive market growth.

Market expansion and innovation in hyperthermia cancer treatment arise from strategic growth opportunities such as combination therapies, personalized treatment approaches, technological advancements, expansion into emerging markets, and strategic collaborations. The breast cancer opportunity has a significant role to play in the progression of hyperthermia therapy and it is useful for business development.

Hyperthermia Cancer Treatment Market Driver and Challenges

This research seeks to provide insights into the various drivers and challenges that shape the development of the hyperthermia cancer treatment market. High costs associated with device production restrict the early entry of competitors and limit profits obtained from these devices, thereby restricting high margins. This report analyzes the factors affecting a company's ability to expand internationally.

The factors responsible for driving the hyperthermia cancer treatment market include:

1. Technological Advancements: Technological advancements improve the efficiency of hyperthermia treatments through enhanced precision and new device technologies. These improvements lead to better targeting of tumor tissues, resulting in improved patient outcomes and expanded treatment options. Further research and development (R&D) activities on device technology drive market growth and adoption.

2. Increasing Cancer Prevalence: The global increase in cancer cases influences the demand for effective therapeutic options like hyperthermia. As cancer rates rise, there is a growing need for complementary or innovative therapies, which leads to an expansion in this market segment. According to industry data forecasts, this trend is expected to continue over time. In summary, there are significant opportunities for the treatment of cancer using hyperthermia.

3. Growing Research Funding: The availability of funds from both government and private sources plays a critical role in promoting research and development activities aimed at improving cancer treatment through hyperthermia. This financial support fosters technological advancements, the expansion of clinical trials, and innovations that contribute to market growth and the creation of new treatment options.

4. Increased Awareness and Acceptance: Increased awareness among healthcare providers and patients about the benefits of hyperthermia drives its adoption and utilization. Hyperthermic therapy has been approved in many countries after successful trials involving women with breast cancer. As awareness grows, its acceptance will likely lead to increased uptake within oncology clinics worldwide.

Challenges in the Hyperthermia Cancer Treatment Market:

1. High Initial Costs: Hyperthermia devices and treatments are expensive, which may limit access due to affordability concerns, especially in markets with lower per capita income or less developed healthcare systems, such as in Africa, including Nigeria. While demand for hyperthermia is increasing due to rising cancer diagnoses, high costs make it difficult for medical providers to afford the technology, limiting its reach, especially in impoverished regions. Reducing these costs is essential to increase accessibility and improve patient outcomes.

2. Limited Clinical Evidence: Market growth for hyperthermia is hindered by a lack of sufficient clinical evidence regarding the efficacy and safety of the treatment. The absence of conclusive clinical trials undermines the treatment's legitimacy and fosters skepticism among healthcare providers, who feel there is not enough data to support its use as a viable option.

3. Regulatory Red Tape: Navigating regulatory requirements and obtaining endorsements for novel hyperthermia machines can be challenging. Regulatory hurdles can slow market entry, increase development costs, and potentially hinder the growth and adoption of hyperthermia treatments.

Technological advancements, increasing cancer incidence, growing research funding, regulatory support, and increased awareness are key drivers shaping the hyperthermia cancer treatment market. However, the market dynamics are also influenced by challenges such as high costs, limited clinical evidence, and regulatory barriers. Addressing these issues while tapping into growth drivers will be crucial for advancing hyperthermia cancer treatment and increasing its impact within the healthcare sector.

List of Hyperthermia Cancer Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hyperthermia cancer treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hyperthermia cancer treatment companies profiled in this report include-

• PYREXAR Medical
• Celsius43
• Hydrosun
• Oncotherm
• Andromedic
• Yamamoto Vinita
• Chongqing Haifu Medical Technology
• innoMedicus
• Gamida-Cell
• RAND

Hyperthermia Cancer Treatment by Segment

The study includes a forecast for the global hyperthermia cancer treatment market by type, application, and region.

Hyperthermia Cancer Treatment Market by Type [Analysis by Value from 2019 to 2031]:

• Local Hyperthermia System
• Whole Body Hyperthermia System

Hyperthermia Cancer Treatment Market by Application [Analysis by Value from 2019 to 2031]:

• Breast Cancer
• Liver Cancer
• Soft Tissue Sarcoma
• Head & Neck Tumors
• Prostate Cancer
• Others

Hyperthermia Cancer Treatment Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Hyperthermia Cancer Treatment Market

Recent developments in the hyperthermia cancer treatment market have been indicative of advancements in technology, research, and clinical practices. Various countries have made significant progress in hyperthermia, which is the process of raising the temperature of cancerous tissues to increase the efficiency of other treatments. Some of these improvements include innovations in equipment, new research findings, and emerging clinical practices. This overview examines recent global market trends, demonstrating what these changes mean for the future of hyperthermia cancer treatments.

• United States: The United States has experienced a major revolution in heat therapy for cancer by incorporating new technological innovations and conducting clinical studies. The use of modern radiofrequency and microwave technology has improved treatment precision, which significantly leads to better patient prognosis. Additionally, clinical trials are being conducted to determine how effective hyperthermia would be when combined with immunotherapy or targeted therapies. The FDA's approval of newly developed hyperthermia devices also contributes to the growth of the industry. Moreover, increased funding for research and development is advancing treatment methods, thereby accelerating the uptake of hyperthermia as an alternative cancer treatment.
• China: Hyperthermia for cancer treatment has undergone numerous developments in China, driven by increased investments in medical technology and research. China aims to create better systems for achieving its objectives in hyperthermia, such as improved magnetized forms and focused ultrasound methodologies. Institutions involved in research have continued to test whether conventional therapies, like chemotherapy and radiation therapy, may be more effective when used alongside hyperthermia. It is worth noting that the Chinese government's emphasis on innovation within the healthcare sector will help facilitate access to various treatment options for patients throughout the country.
• Germany: Germany stands out among European countries for its advancements in hyperthermia cancer treatment, both in terms of equipment and application. German researchers are leading studies on combining novel therapy options, such as personalized medicine, with hyperthermia and targeted therapies. This has led to more effective treatments, thanks to the development of advanced hyperthermia systems with better precision and safety profiles. Germany is therefore well-positioned to scale up the adoption and integration of hyperthermia into clinical practice due to its well-established healthcare infrastructure. Such initiatives are supported by favorable regulations and funding for research, which facilitate innovations and improvements in this field.
• India: Hyperthermia cancer treatment has been gaining popularity in India due to increased awareness and technological developments. For instance, there is a growing trend among patients opting for low-cost heat therapy devices, making the treatment more accessible than ever before. To further demonstrate the efficacy of this combination approach, clinical trials are being conducted by Indian research institutions using hyperthermia alongside other therapies. Furthermore, the Indian government's focus on improving cancer care infrastructure, coupled with increased financial allocation for cancer research, has made it possible for many people in the country to embrace hyperthermia as one of the available solutions.
• Japan: Japan has made notable progress in using heat techniques for cancer treatment, with significant improvements in technology and medical practices. There are now highly developed forms of hyperthermia systems, including high-frequency ones based on magnetic resonance. In addition, Japanese scientists are researching the application of hyperthermia in combination with other innovative methods, such as gene therapy or immunotherapy, to boost overall effectiveness. Furthermore, Japan is focusing on applying new treatments like precision medicine, while developing a healthcare system where these innovations are integrated. Japan's emphasis on innovation, combined with ongoing investment in oncological studies, ensures continued growth in this field.

Features of the Global Hyperthermia Cancer Treatment Market

Market Size Estimates: Hyperthermia cancer treatment market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Hyperthermia cancer treatment market size by type, application, and region in terms of value ($M).

Regional Analysis: Hyperthermia cancer treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the hyperthermia cancer treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hyperthermia cancer treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the hyperthermia cancer treatment market by type (local hyperthermia system and whole body hyperthermia system), application (breast cancer, liver cancer, soft tissue sarcoma, head & neck tumors, prostate cancer, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Hyperthermia Cancer Treatment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Hyperthermia Cancer Treatment Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Hyperthermia Cancer Treatment Market by Type
  • 3.3.1: Local Hyperthermia System
  • 3.3.2: Whole Body Hyperthermia System
• 3.4: Global Hyperthermia Cancer Treatment Market by Application
  • 3.4.1: Breast Cancer
  • 3.4.2: Liver Cancer
  • 3.4.3: Soft Tissue Sarcoma
  • 3.4.4: Head & Neck Tumors
  • 3.4.5: Prostate Cancer
  • 3.4.6: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Hyperthermia Cancer Treatment Market by Region
• 4.2: North American Hyperthermia Cancer Treatment Market
  • 4.2.1: North American Hyperthermia Cancer Treatment Market by Type: Local Hyperthermia System and Whole Body Hyperthermia System
  • 4.2.2: North American Hyperthermia Cancer Treatment Market by Application: Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, Head & Neck Tumors, Prostate Cancer, and Others
• 4.3: European Hyperthermia Cancer Treatment Market
  • 4.3.1: European Hyperthermia Cancer Treatment Market by Type: Local Hyperthermia System and Whole Body Hyperthermia System
  • 4.3.2: European Hyperthermia Cancer Treatment Market by Application: Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, Head & Neck Tumors, Prostate Cancer, and Others
• 4.4: APAC Hyperthermia Cancer Treatment Market
  • 4.4.1: APAC Hyperthermia Cancer Treatment Market by Type: Local Hyperthermia System and Whole Body Hyperthermia System
  • 4.4.2: APAC Hyperthermia Cancer Treatment Market by Application: Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, Head & Neck Tumors, Prostate Cancer, and Others
• 4.5: ROW Hyperthermia Cancer Treatment Market
  • 4.5.1: ROW Hyperthermia Cancer Treatment Market by Type: Local Hyperthermia System and Whole Body Hyperthermia System
  • 4.5.2: ROW Hyperthermia Cancer Treatment Market by Application: Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, Head & Neck Tumors, Prostate Cancer, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Hyperthermia Cancer Treatment Market by Type
  • 6.1.2: Growth Opportunities for the Global Hyperthermia Cancer Treatment Market by Application
  • 6.1.3: Growth Opportunities for the Global Hyperthermia Cancer Treatment Market by Region
• 6.2: Emerging Trends in the Global Hyperthermia Cancer Treatment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Hyperthermia Cancer Treatment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hyperthermia Cancer Treatment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: PYREXAR Medical
• 7.2: Celsius43
• 7.3: Hydrosun
• 7.4: Oncotherm
• 7.5: Andromedic
• 7.6: Yamamoto Vinita
• 7.7: Chongqing Haifu Medical Technology
• 7.8: innoMedicus
• 7.9: Gamida-Cell
• 7.10: RAND